|
ANALYSIS OF GAAP VERSUS GAAP EXCLUDING SPECIAL ITEMS DISCLOSURES | |||||||
|
(Unaudited) | |||||||
|
|
|
Three Months Ended |
| ||||
|
|
|
March 30, |
|
December 29, |
|
March 31, |
|
|
|
|
2013 |
|
2012 |
|
2012 |
|
|
|
|
(in thousands, except per share data) |
| ||||
|
Reconciliation of GAAP gross profit to GAAP gross profit excluding special items: |
|
|
|
|
|
|
|
|
GAAP gross profit |
|
$ 376,102 |
|
$ 363,375 |
|
$ 335,430 |
|
|
GAAP gross profit % |
|
62.2% |
|
60.0% |
|
58.7% |
|
|
|
|
|
|
|
|
|
|
|
Special expense items: |
|
|
|
|
|
|
|
|
Intangible asset amortization |
|
7,777 |
|
8,986 |
|
9,787 |
|
|
Total special expense items |
|
7,777 |
|
8,986 |
|
9,787 |
|
|
GAAP gross profit excluding special expense items |
|
$ 383,879 |
|
$ 372,361 |
|
$ 345,217 |
|
|
GAAP gross profit % excluding special expense items |
|
63.5% |
|
61.5% |
|
60.4% |
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of GAAP operating expenses to GAAP operating expenses excluding special items: |
|
|
|
|
|
|
|
|
GAAP operating expenses |
|
$ 221,824 |
|
$ 245,827 |
|
$ 223,544 |
|
|
|
|
|
|
|
|
|
|
|
Special expense (income) items: |
|
|
|
|
|
|
|
|
Intangible asset amortization |
|
3,903 |
|
3,903 |
|
4,029 |
|
|
Impairment of long-lived assets (1) |
|
- |
|
22,222 |
|
7,712 |
|
|
Severance and restructuring |
|
151 |
|
2,236 |
|
228 |
|
|
Other operating expenses (income), net (2) |
|
1,678 |
|
1,666 |
|
(2,511) |
|
|
Total special expense items |
|
5,732 |
|
30,027 |
|
9,458 |
|
|
GAAP operating expenses excluding special expense items |
|
$ 216,092 |
|
$ 215,800 |
|
$ 214,086 |
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of GAAP net income to GAAP net income excluding special items: |
|
|
|
|
|
|
|
|
GAAP net income |
|
$ 131,388 |
|
$ 76,622 |
|
$ 54,517 |
|
|
|
|
|
|
|
|
|
|
|
Special expense (income) items: |
|
|
|
|
|
|
|
|
Intangible asset amortization |
|
11,680 |
|
12,889 |
|
13,816 |
|
|
Impairment of long-lived assets (1) |
|
- |
|
22,222 |
|
7,712 |
|
|
Severance and restructuring |
|
151 |
|
2,236 |
|
228 |
|
|
Other operating expenses (income) , net (2) |
|
1,678 |
|
1,666 |
|
(2,511) |
|
|
Pre-tax total special expense items |
|
13,509 |
|
39,013 |
|
19,245 |
|
|
Tax effect of special items |
|
(3,806) |
|
(9,555) |
|
(5,445) |
|
|
Reversal of tax reserves |
|
- |
|
- |
|
(2,272) |
|
|
International restructuring implementation (3) |
|
- |
|
18,726 |
|
65,293 |
|
|
Fiscal year 2012 research & development tax credits |
|
(3,899) |
|
- |
|
- |
|
|
Discontinued operations, net of tax (4) |
|
(2,603) |
|
- |
|
(31,809) |
|
|
GAAP net income excluding special expense items |
|
$ 134,589 |
|
$ 124,806 |
|
$ 99,529 |
|
|
|
|
|
|
|
|
|
|
|
GAAP net income per share excluding special expense items: |
|
|
|
|
|
|
|
|
Basic |
|
$ 0.46 |
|
$ 0.43 |
|
$ 0.34 |
|
|
Diluted |
|
$ 0.45 |
|
$ 0.42 |
|
$ 0.33 |
|
|
|
|
|
|
|
|
|
|
|
Shares used in the calculation of earnings per share excluding special expense items: |
|
|
|
|
|
| |
|
Basic |
|
292,888 |
|
292,075 |
|
292,276 |
|
|
Diluted |
|
300,082 |
|
298,759 |
|
300,221 |
|
|
|
|
|
|
|
|
|
|
|
(1) Includes impairment charges relating to wafer fab and end of line manufacturing equipment and land and building held for sale. |
| ||||||
|
(2) Other operating expenses (income), net are primarily for in-process research and development, contingent consideration adjustments related to certain acquisitions, gain relating to sale of land and buildings, and stock option related litigation. | |||||||
|
(3) Includes impact due to international restructuring. |
| ||||||
|
(4) Includes gain on sale, net of tax relating to certain businesses divested. |
|